ORIOLA OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.963 EUR | -1.43% |
|
-7.40% | -11.49% |
| 25/04 | Transcript : Oriola Oyj, Q1 2024 Earnings Call, Apr 25, 2024 | |
| 25/04 | Oriola Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2024 * | 1.55B 1.66B 138B | Sales 2025 * | 1.59B 1.7B 141B | Capitalization | 181M 193M 16.12B |
|---|---|---|---|---|---|
| Net income 2024 * | 9M 9.62M 803M | Net income 2025 * | 17M 18.18M 1.52B | EV / Sales 2024 * | 0.1 x |
| Net cash position 2024 * | 28.76M 30.75M 2.56B | Net cash position 2025 * | 27.9M 29.84M 2.49B | EV / Sales 2025 * | 0.1 x |
| P/E ratio 2024 * |
17.5
x | P/E ratio 2025 * |
10.1
x | Employees | 872 |
| Yield 2024 * |
7.96% | Yield 2025 * |
9% | Free-Float | 70.11% |
More Fundamentals
* Assessed data
More news
Latest transcript on Oriola Oyj
More press releases
More news
| 1 day | -1.43% | ||
| 1 week | -7.40% | ||
| Current month | -5.22% | ||
| 1 month | -3.70% | ||
| 3 months | -13.40% | ||
| 6 months | +6.76% | ||
| Current year | -11.49% |
1 week
0.96
1.07
1 month
0.961.09
Current year
0.961.17
1 year
0.891.46
3 years
0.892.31
5 years
0.892.47
10 years
0.894.65
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 01/12/01 | |
| Director of Finance/CFO | 54 | 01/22/01 | |
| Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 01/23/01 | |
| Director/Board Member | 55 | 01/23/01 | |
Harri Pärssinen
BRD | Director/Board Member | 61 | 31/19/31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.963 | -1.43% | 276,817 |
| 25/24/25 | 0.977 | -6.95% | 506,916 |
| 24/24/24 | 1.05 | -0.94% | 30,531 |
| 23/24/23 | 1.06 | +0.57% | 81,735 |
| 22/24/22 | 1.054 | +1.35% | 78,364 |
Delayed Quote Nasdaq Helsinki, April 26, 2024 at 08:59 pm IST
More quotes
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Sector
Pharmaceuticals
Calendar
18/07/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.963
EUR
Average target price
1.175
EUR
Spread / Average Target
+22.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.49% | 193M | |
| +17.35% | 71.39B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B |
- Stock Market
- Equities
- OKDBV Stock
